This profile was created from public SEC EDGAR information. Is this you? Claim it, correct it or remove it.

Claim it Correct or add Remove it Report a problem

Troy A. Ignelzi

Chief Financial Officer, Rapport Therapeutics, Inc., as of Oct 2026

From SEC EDGAR, not claimed yetUpdated Oct 23, 2026

Troy A. Ignelzi is Chief Financial Officer at Rapport Therapeutics, Inc.

Chief Financial Officer of Rapport Therapeutics, Inc.

Works at

RRapport Therapeutics, Inc.Chief Financial Officerfrom SEC EDGAR

as of Oct 2026, from an SEC filing